Medical Device Pen Testing: FDA vs EU MDR 2026
Medical device pen testing under FDA vs EU MDR: the 5 FDA report elements, MDR Annex I §17.2/17.4, and how one report serves both submissions.
Read articleEvery article in our archive tagged Penetration Testing.
Showing 6 of 6 articles tagged Penetration Testing
Medical device pen testing under FDA vs EU MDR: the 5 FDA report elements, MDR Annex I §17.2/17.4, and how one report serves both submissions.
Read article
What the FDA's Feb 3, 2026 guidance expects for penetration test recency, version-match, post-change re-testing, and pre-submission remediation, plus when a delta re-test will do and when you need a full one.
Read article
How to design penetration test cases from a medical device threat model, the methodology that bridges STRIDE-style threats and concrete bench test execution, with traceability the FDA expects in Slot 7.
Read article
DAST is a subset of FDA-required penetration testing. What the Feb 2026 guidance expects in eSTAR Slot 7, why a Burp scan alone fails review, and how to build a defensible Testing package.
Read article
What the FDA's Feb 2026 premarket cybersecurity guidance says (and doesn't say) about AI-run penetration testing, where AI helps, where it fails a §524B.
Read article
What the FDA's Feb 2026 premarket guidance actually requires for medical device penetration testing - what's inside a real pen test, what's separate.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ FDA submissions.